Targeting the PI3K/AKT/mTOR pathway in gastrointestinal cancers: a comprehensive review of mechanisms, preclinical evidence, and clinical challenges

Faride Kaikavoosnejad, Hamed Haddad Kashani, Khadijeh Dizaji Asl, Zeinab Mazloumi, Ali Keyhani, Seyyede Sepide Ashraf Moosavi, Milad Verdi, Ali Rafat

Open source

DOI
10.1007/s12032-026-03374-8
Published
2026-08-29
Container
Medical Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12032-026-03374-8,
  title = {Targeting the PI3K/AKT/mTOR pathway in gastrointestinal cancers: a comprehensive review of mechanisms, preclinical evidence, and clinical challenges},
  author = {Faride Kaikavoosnejad and Hamed Haddad Kashani and Khadijeh Dizaji Asl and Zeinab Mazloumi and Ali Keyhani and Seyyede Sepide Ashraf Moosavi and Milad Verdi and Ali Rafat},
  year = {2026},
  journal = {Medical Oncology},
  doi = {10.1007/s12032-026-03374-8},
  url = {https://doi.org/10.1007/s12032-026-03374-8}
}

RIS

TY  - JOUR
TI  - Targeting the PI3K/AKT/mTOR pathway in gastrointestinal cancers: a comprehensive review of mechanisms, preclinical evidence, and clinical challenges
AU  - Faride Kaikavoosnejad
AU  - Hamed Haddad Kashani
AU  - Khadijeh Dizaji Asl
AU  - Zeinab Mazloumi
AU  - Ali Keyhani
AU  - Seyyede Sepide Ashraf Moosavi
AU  - Milad Verdi
AU  - Ali Rafat
PY  - 2026
JO  - Medical Oncology
DO  - 10.1007/s12032-026-03374-8
UR  - https://doi.org/10.1007/s12032-026-03374-8
ER  - 

APA

Kaikavoosnejad, F., Kashani, H. H., Asl, K. D., Mazloumi, Z., Keyhani, A., Moosavi, S. S. A., Verdi, M., & Rafat, A. (2026). Targeting the PI3K/AKT/mTOR pathway in gastrointestinal cancers: a comprehensive review of mechanisms, preclinical evidence, and clinical challenges. Medical Oncology. https://doi.org/10.1007/s12032-026-03374-8

Source records